Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection

Summary

After performing VATS pulmonary wedge resections, a chest tube is routinely left in the pleural cavity to drain possible air leaks and fluid accumulations. Chest tubes after VATS pulmonary wedge resections are left in place a minimum of 1 day. However, this practice has no scientific foundations. The investigators believe it is possible to avoid the placement of a chest tube after this procedure in a great amount of patients. This is a randomized controlled clinical trial with analysis blinding in which the investigators want to compare the outcomes between installing a chest tube or not after VATS pulmonary wedge resections. The investigators will include consecutively patients with interstitial lung disease or indeterminate pulmonary nodules undergoing this procedure, at the participating institutions. The investigators calculated a sample size of 50 subjects in each group using pneumothorax \< 10% data from Luckraz et al and to determine a difference of hospital stay of 2 versus 1 day; DS(1.5), power = 0.9 and alpha = 0.05.

Conditions

• Lung Diseases, Interstitial
• Pulmonary Nodule, Solitary

Interventions

PROCEDURE

Do not leave a chest tube in the pleural cavity.

At the end of a VATS wedge resection, an air leak proof will take place and if no air leak is noted, the surgical incisions for thoracoscopy ports will be closed without leaving a chest tube inserted in the pleural cavity of the patient.

PROCEDURE

Do leave a chest tube in the pleural cavity.

At the end of a VATS wedge resection, a chest tube will be inserted in the pleural cavity of the patient through the inferior surgical incision for thoracoscopy port; the rest of the incisions will be closed.

Sponsors & Collaborators

• Universidad Industrial de Santander

  collaborator OTHER

• Clinica Chicamocha

  collaborator UNKNOWN

• Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle

  lead OTHER

Principal Investigators

• Leonidas Tapias, MD · Fundacion Oftalmológica de Santander Clinica Carlos Ardila Lulle

• Luis C Orozco-Vargas, MD · Universidad Industrial de Santander

• Luis F Tapias-Vargas · Universidad Industrial de Santander

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

16 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2008-07-31

Primary Completion

2012-06-30

Completion

2012-06-30

Countries

• Colombia

Study Locations